ID   HOM-2
AC   CVCL_A612
SY   HOM 2; HOM2
DR   BTO; BTO:0003106
DR   dbMHC; 48898
DR   ECACC; 98092902
DR   IHW; IHW09005
DR   IPD-IMGT/HLA; 10755
DR   Wikidata; Q54890143
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=158761;
RX   PubMed=7614994;
RX   PubMed=8813743;
RX   PubMed=29171935;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   HLA typing: A*03:01:01:01; B*27:05:02; C*01:02:01:06; DPA1*01; DPB1*04:01:01; DQA1*01:01; DQB1*05:01:01; DRA*01:01; DRB1*01:01:01; DRB6*01:01 (IPD-IMGT/HLA=10755).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 20
//
RX   DOI=10.1007/978-1-4612-3552-1_2;
RA   Yang S.Y., Milford E.L., Hammerling U., Dupont B.;
RT   "Description of the reference panel of B-lymphoblastoid cell lines for
RT   factors of the HLA system: the B-cell line panel designed for the
RT   Tenth International Histocompatibility Workshop.";
RL   (In) Immunobiology of HLA. Volume I. Histocompatibility testing 1987; Dupont B. (eds.); pp.11-19; Springer; New York (1989).
//
RX   DOI=10.1007/978-1-4612-3552-1_4;
RA   Mickelson E., Reinsmoen N., Robbins F.-M., Hartzman R.J., Odum N.,
RA   Svejgaard A., Farrell C., Honeyman M., Flomenberg N., Sell T.,
RA   Eckels D.;
RT   "HLA-Dw and HLA-DP typing of the reference panel of B-lymphoblastoid
RT   cell lines.";
RL   (In) Immunobiology of HLA. Volume I. Histocompatibility testing 1987; Dupont B. (eds.); pp.38-42; Springer; New York (1989).
//
RX   DOI=10.1007/978-1-4612-3552-1_5;
RA   Yang S.Y.;
RT   "Assignment of HLA-A and HLA-B antigens for the reference panel of
RT   B-lymphoblastoid cell lines determined by one-dimensional isoelectric
RT   focusing (lD-IEF) gel electrophoresis.";
RL   (In) Immunobiology of HLA. Volume I. Histocompatibility testing 1987; Dupont B. (eds.); pp.43-44; Springer; New York (1989).
//
RX   DOI=10.1007/978-1-4612-3552-1_6;
RA   Knowles R.W.;
RT   "Assignment of HLA-class II alpha and beta chain 2-D gel patterns for
RT   the workshop reference panel of B-lymphoblastoid cell lines.";
RL   (In) Immunobiology of HLA. Volume I. Histocompatibility testing 1987; Dupont B. (eds.); pp.44-46; Springer; New York (1989).
//
RX   DOI=10.1007/978-1-4612-3552-1_7;
RA   Flomenberg N.;
RT   "Assignment of T-cell-defined (TCD) HLA class II specificities for the
RT   reference panel of B-lymphoblastoid cell lines.";
RL   (In) Immunobiology of HLA. Volume I. Histocompatibility testing 1987; Dupont B. (eds.); pp.46-48; Springer; New York (1989).
//
RX   PubMed=158761; DOI=10.1073/pnas.76.7.3507;
RA   Farrant J., Knight S.C.;
RT   "Help and suppression by lymphoid cells as a function of cellular
RT   concentration.";
RL   Proc. Natl. Acad. Sci. U.S.A. 76:3507-3510(1979).
//
RX   PubMed=7614994; DOI=10.1002/eji.1830250627;
RA   Wedderburn L.R., Searle S.J.M., Rees A.R., Lamb J.R., Owen M.J.;
RT   "Mapping T cell recognition: the identification of a T cell receptor
RT   residue critical to the specific interaction with an influenza
RT   hemagglutinin peptide.";
RL   Eur. J. Immunol. 25:1654-1662(1995).
//
RX   PubMed=8813743; DOI=10.1111/j.1399-0039.1996.tb02596.x;
RA   Prasad V.K., Yang S.Y.;
RT   "Allele assignment for HLA-A, -B, and -C genes to the Tenth
RT   International Histocompatibility Workshop cell lines.";
RL   Tissue Antigens 47:538-546(1996).
//
RX   PubMed=29171935; DOI=10.1111/tan.13184;
RA   Turner T.R., Hayhurst J.D., Hayward D.R., Bultitude W.P., Barker D.J.,
RA   Robinson J., Madrigal J.A., Mayor N.P., Marsh S.G.E.;
RT   "Single molecule real-time DNA sequencing of HLA genes at ultra-high
RT   resolution from 126 international HLA and immunogenetics workshop cell
RT   lines.";
RL   HLA 91:88-101(2018).
//